20 May 2015

Anti-Germ acquires Esteer Pharma

Anti-Germ, the market leading specialist for hygiene and disinfection solutions for the food value chain, today announced that it acquired Esteer Pharma.

Esteer Pharma is specialized in hand and skin disinfection, treatment of medical instruments and the disinfection and cleaning of surfaces and equipment. The company has a leading technology position and a strong foothold in its market in Southern Europe and the Middle East. Given Esteer Pharma’s complimentary product ranges, the acquisition helps Anti-Germ to solidify its offering of hospital hygiene.

About Anti-Germ

Fuelled by almost two centuries of experience in hygiene for professional outlets, Anti-Germ provides market leading systems of products, technologies and services for the food value chain. Anti-Germ is headquartered in Memmingen, Germany with additional production sites in Vaas (France) und Neumarkt (Austria) as well as subsidiaries in six further countries. For further information, visit the company’s website www.anti-germ.com.

About Paragon

Paragon is one of the leading independent private equity firms in Europe with approx. €650 million of equity under management. Paragon works closely with portfolio companies to achieve sustainable growth and operational excellence. The investment portfolio covers various industries and currently comprises 7 companies. Paragon was founded in 2004 and is based in Munich, Germany. For further information please refer to www.paragon.de.